rs1456036053

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_001385089.1(BEGAIN):​c.1633G>C​(p.Val545Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000651 in 1,536,986 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0000065 ( 0 hom. )

Consequence

BEGAIN
NM_001385089.1 missense

Scores

1
2
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.12

Publications

0 publications found
Variant links:
Genes affected
BEGAIN (HGNC:24163): (brain enriched guanylate kinase associated) Predicted to be involved in regulation of postsynaptic neurotransmitter receptor activity. Predicted to act upstream of or within evoked excitatory postsynaptic potential. Predicted to be located in dendrite; nucleus; and presynapse. Predicted to be active in glutamatergic synapse and postsynapse. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.17848742).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
BEGAINNM_001385089.1 linkc.1633G>C p.Val545Leu missense_variant Exon 7 of 7 ENST00000554140.3 NP_001372018.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
BEGAINENST00000554140.3 linkc.1633G>C p.Val545Leu missense_variant Exon 7 of 7 5 NM_001385089.1 ENSP00000451125.2 G3V3A2

Frequencies

GnomAD3 genomes
AF:
0.00000658
AC:
1
AN:
152066
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00
AC:
0
AN:
140816
AF XY:
0.00
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000650
AC:
9
AN:
1384920
Hom.:
0
Cov.:
31
AF XY:
0.00000878
AC XY:
6
AN XY:
683220
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
31304
American (AMR)
AF:
0.00
AC:
0
AN:
35482
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
22830
East Asian (EAS)
AF:
0.00
AC:
0
AN:
37074
South Asian (SAS)
AF:
0.00
AC:
0
AN:
76606
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
41840
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5130
European-Non Finnish (NFE)
AF:
0.00000835
AC:
9
AN:
1077388
Other (OTH)
AF:
0.00
AC:
0
AN:
57266
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00000658
AC:
1
AN:
152066
Hom.:
0
Cov.:
33
AF XY:
0.0000135
AC XY:
1
AN XY:
74270
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41424
American (AMR)
AF:
0.00
AC:
0
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5156
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
67956
Other (OTH)
AF:
0.00
AC:
0
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000378

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Sep 26, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.1576G>C (p.V526L) alteration is located in exon 6 (coding exon 6) of the BEGAIN gene. This alteration results from a G to C substitution at nucleotide position 1576, causing the valine (V) at amino acid position 526 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.070
T
BayesDel_noAF
Benign
-0.34
CADD
Benign
13
DANN
Benign
0.83
DEOGEN2
Benign
0.018
.;T;.;T
Eigen
Benign
-0.49
Eigen_PC
Benign
-0.41
FATHMM_MKL
Uncertain
0.88
D
LIST_S2
Benign
0.81
T;.;T;T
M_CAP
Uncertain
0.20
D
MetaRNN
Benign
0.18
T;T;T;T
MetaSVM
Benign
-0.92
T
MutationAssessor
Benign
0.69
.;N;.;N
PhyloP100
2.1
PrimateAI
Pathogenic
0.85
D
PROVEAN
Benign
-0.75
.;N;.;N
REVEL
Benign
0.061
Sift
Benign
0.26
.;T;.;T
Sift4G
Benign
0.25
.;T;.;T
Polyphen
0.026
.;B;.;B
Vest4
0.16, 0.18
MutPred
0.26
.;Gain of catalytic residue at G521 (P = 0.01);.;Gain of catalytic residue at G521 (P = 0.01);
MVP
0.13
MPC
0.44
ClinPred
0.29
T
GERP RS
3.4
Varity_R
0.24
gMVP
0.16
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1456036053; hg19: chr14-101004512; API